1 Min Read
Oct 12 (Reuters) - BERGENBIO ASA
* CLINICAL TRIAL OF BGB324 WILL BE PRESENTED AT 9TH WORLD CONGRESS OF MELANOMA IN BRISBANE, AUSTRALIA, OCTOBER 18-21, 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.